InvestorsHub Logo
Followers 6
Posts 679
Boards Moderated 2
Alias Born 03/15/2013

Re: ThePennyDoctor post# 1754

Wednesday, 08/07/2013 9:25:26 PM

Wednesday, August 07, 2013 9:25:26 PM

Post# of 3274
I don't know what this means, but I just found it on their website. Doesn't sound good though.

Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock

08/07/2013
THE WOODLANDS, Texas--(BUSINESS WIRE)-- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced the pricing of an underwritten public offering of 12 million shares of its common stock at a price to the public of $1.50 per share. The gross proceeds to Opexa from this offering are expected to be approximately $18 million, before deducting underwriting discounts and commissions and other estimated offering expenses. All of the shares in the offering are to be sold by Opexa. Opexa has also granted the underwriters a 30-day option to purchase up to an additional 1.8 million shares of common stock to cover over-allotments, if any. The offering is expected to close on or about August 13, 2013, subject to customary closing conditions.


http://www.opexatherapeutics.com/investors-relations/press-releases/press-release-details/2013/Opexa-Therapeutics-Inc-Announces-Pricing-of-Public-Offering-ofCommonStock/default.aspx

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.